Small Molecule Mitophagy Therapeutics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
76
NCT06721091
Safety, Tolerability, and Dose Response of VNA-318 in Healthy Males
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 3, 2024
Completion: Nov 30, 2025
Loading map...